Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paulo Batista de Carvalho"'
Autor:
Géssica Oliveira Mendes, Moysés Fagundes de Araújo Neto, Deyse Brito Barbosa, Mayra Ramos do Bomfim, Lorena Silva Matos Andrade, Paulo Batista de Carvalho, Tiago Alves de Oliveira, Daniel Luciano Falkoski, Eduardo Habib Bechelane Maia, Marcelo Siqueira Valle, Laila Cristina Moreira Damázio, Alisson Marques da Silva, Alex Gutterres Taranto, Franco Henrique Andrade Leite
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1645 (2023)
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive loss of cognitive functions, and it is the most prevalent type of dementia worldwide, accounting for 60 to 70% of cases. The pathogenesis of AD seems to involve th
Externí odkaz:
https://doaj.org/article/1e4067c1685d40df87a093a2fee6cdc4
Autor:
Géssica Oliveira Mendes, Samuel Silva da Rocha Pita, Paulo Batista de Carvalho, Michel Pires da Silva, Alex Gutterres Taranto, Franco Henrique Andrade Leite
Publikováno v:
Pharmaceuticals, Vol 16, Iss 6, p 880 (2023)
Alzheimer’s Disease (AD) is a neurodegenerative condition characterized by progressive memory loss and other affected cognitive functions. Pharmacological therapy of AD relies on inhibitors of the enzymes acetylcholinesterase (AChE) and butyrylchol
Externí odkaz:
https://doaj.org/article/6c0d5eb7386544ac830fa9adc5d1a850
Autor:
Tiago Alves de Oliveira, Lucas Rolim Medaglia, Eduardo Habib Bechelane Maia, Letícia Cristina Assis, Paulo Batista de Carvalho, Alisson Marques da Silva, Alex Gutterres Taranto
Publikováno v:
Pharmaceuticals, Vol 15, Iss 2, p 132 (2022)
DNA is a molecular target for the treatment of several diseases, including cancer, but there are few docking methodologies exploring the interactions between nucleic acids with DNA intercalating agents. Different docking methodologies, such as AutoDo
Externí odkaz:
https://doaj.org/article/adfe93ce80514a20b6cc6c00e53c21ca
Autor:
Leite, Géssica Oliveira Mendes, Samuel Silva da Rocha Pita, Paulo Batista de Carvalho, Michel Pires da Silva, Alex Gutterres Taranto, Franco Henrique Andrade
Publikováno v:
Pharmaceuticals; Volume 16; Issue 6; Pages: 880
Alzheimer’s Disease (AD) is a neurodegenerative condition characterized by progressive memory loss and other affected cognitive functions. Pharmacological therapy of AD relies on inhibitors of the enzymes acetylcholinesterase (AChE) and butyrylchol
Autor:
Mayra Ramos do Bomfim, Deyse Brito Barbosa, Paulo Batista de Carvalho, Alisson Marques da Silva, Tiago Alves de Oliveira, Alex Gutterres Taranto, Franco Henrique Andrade Leite
Publikováno v:
Journal of Biomolecular Structure and Dynamics. :1-15
Alzheimer's disease (AD) is a neurodegenerative pathology responsible for 70% of dementia cases worldwide. Despite its relevance, the few drugs available for the treatment of this disease offer only symptomatic relief, with limited efficacy and serio